Exchange Traded Concepts, LLC Nrx Pharmaceuticals, Inc. Transaction History

Exchange Traded Concepts, LLC

  • $4.18 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 17, 2023
BUY
$0.79 - $9.19 $12,894 - $149,999
16,322 Added 153.95%
26,924 $30,000
Q3 2022

Oct 07, 2022
BUY
$0.2 - $8.07 $240 - $9,684
1,200 Added 12.76%
10,602 $8,000
Q2 2022

Jul 20, 2022
BUY
$0.51 - $2.42 $3,829 - $18,169
7,508 Added 396.41%
9,402 $6,000
Q1 2022

Apr 26, 2022
BUY
$2.45 - $5.04 $4,640 - $9,545
1,894 New
1,894 $5,000

Others Institutions Holding NRXP

# of Institutions
2
Shares Held
17.4K
Call Options Held
0
Put Options Held
0
View Full List

About NRX Pharmaceuticals, Inc.

NRXP Quotes by TradingView
  • Ticker NRXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,641,296
  • Market Cap $101M
  • Description
  • NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...
More about NRXP
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email